Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward O Reiter

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Hormone Research|January 18, 2007
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short statureMichael B Ranke, Anders Lindberg, David A Price, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 27, 2009
Metabolic abnormalities in human immunodeficiency virus-infected children: two-year follow-upJens C Krause, Mary P Toye, Donna J Fisher, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)Michael B Ranke, Anders Lindberg, Christopher T Cowell, et al.
Hormone Research|September 5, 2003
The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiencyEdward O Reiter, Anders Lindberg, Michael B Ranke, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 17, 2010
Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT)Edward O Reiter, Nelly Mauras, Ken McCormick, et al.
Hormone Research|March 12, 2005
Insulin-like growth factors as diagnostic tools in growth hormone deficiency during childhood and adolescence: the KIGS experienceMichael B Ranke, Roland Schweizer, Anders Lindberg, et al.
Hormone Research|January 4, 2005
Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database)Feyza Darendeliler, Michael B Ranke, Bert Bakker, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|January 4, 2003
A growth prediction model for short children born small for gestational ageMichael B Ranke, Wayne S Cutfield, Anders Lindberg, et al.
Endocrine Pathology|January 1, 1995
Y Chromosomal Sequences Identified in Gonadal Tissue of Two 45,X Patients with Turner SyndromeMirjana Kocova, Selma Feldman Witchel, Michael Nalesnik, et al.
Clinical Endocrinology|August 5, 2006
Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database)Maria E Craig, Christopher T Cowell, Pontus Larsson, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Hormone Research|January 18, 2007
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short statureMichael B Ranke, Anders Lindberg, David A Price, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 27, 2009
Metabolic abnormalities in human immunodeficiency virus-infected children: two-year follow-upJens C Krause, Mary P Toye, Donna J Fisher, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)Michael B Ranke, Anders Lindberg, Christopher T Cowell, et al.
Hormone Research|September 5, 2003
The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiencyEdward O Reiter, Anders Lindberg, Michael B Ranke, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 17, 2010
Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT)Edward O Reiter, Nelly Mauras, Ken McCormick, et al.
Hormone Research|March 12, 2005
Insulin-like growth factors as diagnostic tools in growth hormone deficiency during childhood and adolescence: the KIGS experienceMichael B Ranke, Roland Schweizer, Anders Lindberg, et al.
Hormone Research|January 4, 2005
Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database)Feyza Darendeliler, Michael B Ranke, Bert Bakker, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|January 4, 2003
A growth prediction model for short children born small for gestational ageMichael B Ranke, Wayne S Cutfield, Anders Lindberg, et al.
Endocrine Pathology|January 1, 1995
Y Chromosomal Sequences Identified in Gonadal Tissue of Two 45,X Patients with Turner SyndromeMirjana Kocova, Selma Feldman Witchel, Michael Nalesnik, et al.
Clinical Endocrinology|August 5, 2006
Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database)Maria E Craig, Christopher T Cowell, Pontus Larsson, et al.
Pageof 4